OMERS Administration Corporation
+0.18%
3M Return
$10.510
+0.131 (+1.25%)Zum Schluss
Xanadu Quantum Technologies Limited is a Canada-based quantum computing company. The Company is focused on providing quantum computer services available on the cloud with supporting software, along with quantum simulators and other related products and offerings.
Xanadu Quantum Technologies Ltd (XNDU) is a good buy right now, primarily driven by its recent announcement of securing CAD $195 million in government funding for its new advanced facility, which significantly enhances its growth potential. The current price of $10.51 is well below the analyst price targets, with CIBC and Canaccord setting targets at $22 and $45 respectively, indicating substantial upside potential. Additionally, the company has a strong cash position of $312.8 million, which supports ongoing R&D investments despite a recent GAAP loss of $0.14 per share, reflecting the challenges in profitability. However, the main risk is the company's negative earnings per share (EPS) forecast, which remains at -0.03 for Q3 2024, indicating ongoing financial challenges that could impact investor sentiment.

Xanadu Quantum Technologies Secures CAD $195 Million for Advanced Facility

Canadian Government Backs Xanadu's Quantum Computing Initiative

Xanadu and Mitsubishi Chemical Advance Semiconductor Collaboration

Xanadu and Mitsubishi Chemical Deepen Collaboration on Quantum Semiconductor Technologies

Xanadu to Host Technological Roadmap Presentation on August 31, 2026
Xanadu Quantum Technologies Limited is a Canada-based quantum computing company. The Company is focused on providing quantum computer services available on the cloud with supporting software, along with quantum simulators and other related products and offerings. It operates in the Technology sector.
Xanadu Quantum Technologies Ltd (XNDU) is a good buy right now, primarily driven by its recent announcement of securing CAD $195 million in government funding for its new advanced facility, which significantly enhances its growth potential. The current price of $10.51 is well below the analyst price targets, with CIBC and Canaccord setting targets at $22 and $45 respectively, indicating substantial upside potential. Additionally, the company has a strong cash position of $312.8 million, which supports ongoing R&D investments despite a recent GAAP loss of $0.14 per share, reflecting the challenges in profitability. However, the main risk is the company's negative earnings per share (EPS) forecast, which remains at -0.03 for Q3 2024, indicating ongoing financial challenges that could impact investor sentiment.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.